More Information

Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation : A Reference Guide to Fetal and Neonatal Risk. 7th ed. Baltimore: William & Wilkins;2005:1071-2.

Brown JW.

Toxic megacolon associated with loperamide therapy.

JAMA 1979;241(5):501-2.

Cohen, SH, Gerding DN, Johnson S et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and Infectious Disease Society of America (IDSA). Source: Infection Control and Hospital Epidemiology 2010;31(5): 431-55: http://www.jstor.org/stable/10.1086/651706 (Accessed July 23, 2015).

Chen, J, Lau E (Editors): Drug Handbook and Formulary 2015, Hospital for Sick Children (Toronto).

Cunningham R, Dale B, Undy B, et al. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003;54:243-5.

Dial S, Alrasadi K, Manoukian C, et al. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case– control studies. CMAJ 2004;171(1):33-8.

Dial S, Delaney JAC, Barkun AN, et al. Use of gastric acid suppressive agents and the risk of community-acquired Clostridium difficile associated disease. JAMA 2005;294:2989-95

McDonald, L. Clifford, et al. Clinical practice guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases 2018;66(7): e1-e48. https://academic.oup.com/cid/article/66/7/e1/4855916 (Accessed April 27, 2018).

Ontario Ministry of Health and Long-Term Care. Provincial Infectious Diseases Advisory Committee (PIDAC). (2010). Annex C: Testing, Surveillance and Management of Clostridium difficile in All Health Care Settings. Available Here

Ontario Ministry of Health and Long Term Care. Public Health Division.(2014). Roles and Responsibilities of Hospitals and Public Health Units for Clostridium difficile Infection (CDI) Reporting and Outbreak Management. Available Here

Poutanen S, Simor A. Clostridium difficile Infection in adults. CMAJ 2004;171(1):51-58.

Schutze GE, Willoughby RE, Committee on Infectious Diseases, American Academy of Pediatrics. POLICY STATEMENT Clostridium difficile infection in infants and children. Pediatrics 2013; 131:196.

Up to Date; Clostridium difficile infection in children: Treatment. Accessed April 27, 2018.

Upton AD. Canadian Pediatric Society Infectious Diseases and Immunization Committee.

Clostridium Difficile in Paediatric Populations; Peadiatric Child Health 2014; 19(1):43-48.

http://www.cps.ca/documents/position/clostridium-difficile-in-paediatric-populations (Accessed July 23, 2015).

Walley T, Milson D. Loperamide related toxic megacolon in Clostridium difficile colitis.

Postgrad Med J 1990; 66: 582- 584.